Niagen Bioscience, Inc. Reports Second Quarter 2026 Financial Results

Go back to Niagen Bioscience, Inc. Reports Second Quarter 2026 Financial Results
(NASDAQ: NAGE) Delayed: 2.68 -0.11 (3.94%)
Previous Close $2.79    52 Week High $ 
Open $2.79    52 Week Low $ 
Day High $2.79    P/E N/A 
Day Low $2.67    EPS $ 
Volume 865,143